| Concise review: current status of three-dimensional organoids as preclinical models G Kaushik, MP Ponnusamy, SK Batra Stem Cells 36 (9), 1329-1340, 2018 | 155 | 2018 |
| Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma R Kanteti, T Mirzapoiazova, JJ Riehm, I Dhanasingh, B Mambetsariev, ... Cancer biology & therapy 19 (4), 316-327, 2018 | 96 | 2018 |
| MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling I Lakshmanan, S Rachagani, R Hauke, SR Krishn, S Paknikar, ... Oncogene 35 (31), 4112-4121, 2016 | 78 | 2016 |
| MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention S Karmakar, G Kaushik, R Nimmakayala, S Rachagani, MP Ponnusamy, ... Seminars in cancer biology 54, 63-71, 2019 | 53 | 2019 |
| Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells S Barkeer, S Chugh, S Karmakar, G Kaushik, S Rauth, S Rachagani, ... BMC cancer 18, 1-15, 2018 | 52 | 2018 |
| Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis G Kaushik, P Seshacharyulu, S Rauth, P Nallasamy, S Rachagani, ... Oncogene 40 (4), 848-862, 2021 | 47 | 2021 |
| Preclinical in vitro and in vivo models for adoptive cell therapy of cancer G Kaushik, S Venkatesha, B Verma, B Vishwakarma, AH Zhang, A Wesa The Cancer Journal 28 (4), 257-262, 2022 | 3 | 2022 |
| Targeted therapy for cancer stem cells RK Nimmakayala, S Karmakar, G Kaushik, S Rauth, S Barkeer, ... Gene rgulation and therapeutics for cancer. CRC Press, Baco Raton, 2021 | 2 | 2021 |
| 4 3D Coculture platform reveals insights into patient autologous immune cell-tumor interaction and immune modulation in vitro G Kaushik, A Wesa Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A4-A4, 2021 | 1 | 2021 |
| Unique 3D organoids autologous TIL coculture platform enables high throughput immune-oncology drug response studies G Kaushik, P Kamineny, A Wesa Cancer Research 81 (13_Supplement), 2978-2978, 2021 | 1 | 2021 |
| Raptamer-drug conjugates as molecularly targeted cancer therapeutics SP Vega, NE Ward, U Saini, L Castan-Chibas, G Kaushik, D Ciznadija, ... Cancer Research 84 (6_Supplement), 3210-3210, 2024 | | 2024 |
| Unveiling the correlation between gemtuzumab-ozogamicin efficacy and CD33+ expression in AML primary samples using the novel AML vitroscreen M Gilardi, G Kaushik, B Walling, P Schiavini, S Cairo, M Zipeto Cancer Research 84 (6_Supplement), 2064-2064, 2024 | | 2024 |
| Correlation Revealed between Gemtuzumab-Ozogamicin Efficacy and CD33+ Expression in AML Primary Samples through a Novel AML in Vitro Model M Gilardi, G Kaushik, B Walling, V Sambandam, P Schiavini, S Cairo, ... Blood 142, 7151, 2023 | | 2023 |
| CO-1008, an ADC program targeting leukemic progenitor and blast AML cells, but not normal hematopoetic progenitor cells G Kaushik, B Vishwakarma, M Bell, K Komurov Cancer Research 83 (7_Supplement), 1548-1548, 2023 | | 2023 |
| 88 Development of a 3D organoid autologous TIL co-culture platform for high throughput immuno-oncology studies G Kaushik, B Verma, A Wesa Journal for ImmunoTherapy of Cancer 8 (Suppl 3), A56-A56, 2020 | | 2020 |
| Pre-clinical development of ISOX; A novel therapy for pancreatic cancer identified utilizing system biology approach (s) P Atri, P Seshacharyulu, S Rachagani, P Nallasamy, S Rauth, G Kaushik, ... Cancer Research 79 (13_Supplement), 4804-4804, 2019 | | 2019 |
| Developing Targeted Therapy against Pancreatic Cancer G Kaushik | | 2019 |
| Targeting Cancer Stem Cells: A Major Improvement for Therapeutic Efficacy in Lethal Pancreatic Cancer G Kaushik, P Seshacharyulu, S Rachagani, I Lakshmanan, ... PANCREAS 46 (10), 1410-1410, 2017 | | 2017 |
| Targeting pancreatic cancer stem cells by afatinib in organoid culture G Kaushik, P Seshacharyulu, S Rachagani, MA Macha, MP Ponnusamy, ... Cancer Research 76 (14_Supplement), 1726-1726, 2016 | | 2016 |
| AlphaMed Press ME Bateman, AL Strong, JM Gimble, BA Bunnell, G Kaushik, ... | | |
Parthasarathy SeshacharyuluAssistant professor, Department of Biochemistry and Molecular Biology, University of NebraskaVerified email at unmc.edu
